Clinical Trials
15 trialsNCT05156125 2026-04-30
VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Oppilan Pharma Ltd
Phase 2 Terminated
NCT05785715 2025-07-01
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
AbbVie
Phase 2 Terminated
NCT05579444 2023-12-15
Systems Biology of Gastrointestinal and Related Diseases
Viome
Terminated
NCT03656627 2023-02-15
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Alliance Foundation Trials, LLC.
Phase 1 Terminated
NCT03802214 2020-12-21
Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)Therapy
Stanford University
Terminated
NCT01805791 2020-01-02
A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
Hutchmed
Phase 3 Terminated
NCT03455751 2019-03-18
PPaM
The Cleveland Clinic
Phase NA Terminated
NCT00663819 2018-04-17
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
W.L.Gore & Associates
Phase NA Terminated
NCT02182466 2017-12-15
DEKOR
Johann Wolfgang Goethe University Hospital
Terminated
NCT01026480 2017-03-17
IPAA
Boston Medical Center
Terminated
NCT02092389 2017-02-23
AdaProQuo
AbbVie
Terminated
NCT02266849 2016-10-11
Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study
Odense University Hospital
Phase 3 Terminated
NCT00659867 2016-09-27
Endomicroscopy in Ulcerative Colitis
PENTAX Europe GmbH
Phase NA Terminated
NCT01002287 2014-11-20
An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery
Integra LifeSciences Corporation
Phase NA Terminated
NCT00152841 2009-03-17
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
University Health Network, Toronto
Phase 2 Terminated